Search - tctmd.com

Displaying 901 - 920 of 1032

Sort: Relevancy | Date

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

Presentation

GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice

Presenter: Davide Capodanno

July 23, 2014

News Industry News

First Patient Enrolled in PROSPECT II Clinical Trial

June 13, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Industry News

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

May 29, 2014

News Industry News

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

May 23, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

News Industry News

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

May 13, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

Presentation CIT 2014

Science Behind Bioresorbable Vascular Scaffolds

Presenter: Renu Virmani

March 20, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Daily News

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

January 22, 2014

News Daily News

Bioresorbable Scaffold Performs Well in Select STEMI Patients

January 22, 2014

News Daily News

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

January 22, 2014

News Daily News

Andamio Bioabsorbible Funciona Bien en Pacientes STEMI Seleccionados

January 22, 2014

Advertisement

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice

First Patient Enrolled in PROSPECT II Clinical Trial

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Science Behind Bioresorbable Vascular Scaffolds

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

Bioresorbable Scaffold Performs Well in Select STEMI Patients

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

Andamio Bioabsorbible Funciona Bien en Pacientes STEMI Seleccionados

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content